Risk of cardiovascular diseases associated with or... Catalogue en ligne

Titre :	Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. (1999)
Auteurs :	N.R. POULTER ; C.L. CHANG ; T.M.M. FARLEY ; O. MEIRIK ; Cardiovascular Studies Unit. Department of Clinical Pharmacology. Imperial College School of Medicine. London. GBR ; Undp. Unfpa. World Bank Who Special Programme of Research. Development. And Research Training In Human Reproduction. Who. Geneva. CHE
Type de document :	Article
Dans :	Lancet (The) (vol. 354, n° 9190, 1999)
Pagination :	1610-
Langues:	Anglais
Mots-clés :	Thérapeutique ; Facteur risque ; Etude comparée ; OMS ; Recommandation ; Femme ; Homme ; Royaume Uni ; Europe ; Appareil circulatoire [pathologie] ; Vaisseau sanguin [pathologie]
Résumé :	[BDSP. Notice produite par INIST R0xE4mGP. Diffusion soumise à autorisation]. Data from the WHO Collaborative Study suggest that use of progestagen preparations with therapeutic Indications are associated with a significantly increased risk of venous thromboembolism but not stroke or myocardial infarction.

PORTAIL DOCUMENTAIRE